As of 2026-04-06, the Relative Valuation of Boston Scientific Corp (BSX) is 59.69 USD. This relative valuation is based on P/E multiples. With the latest stock price at 62.82 USD, the upside of Boston Scientific Corp based on Relative Valuation is -5.0%.
The range of the Relative Valuation is 53.38 - 68.30 USD.
| Range | Selected | |
| Trailing P/E multiples | 30.1x - 35.0x | 31.6x |
| Forward P/E multiples | 25.2x - 28.8x | 27.2x |
| Fair Price | 53.38 - 68.30 | 59.69 |
| Upside | -15.0% - 8.7% | -5.0% |
| Date | P/E |
| 2026-04-02 | 32.16 |
| 2026-04-01 | 31.74 |
| 2026-03-31 | 32.12 |
| 2026-03-30 | 32.21 |
| 2026-03-27 | 35.41 |
| 2026-03-26 | 35.92 |
| 2026-03-25 | 35.72 |
| 2026-03-24 | 34.88 |
| 2026-03-23 | 35.59 |
| 2026-03-20 | 35.56 |
| 2026-03-19 | 35.77 |
| 2026-03-18 | 36.49 |
| 2026-03-17 | 36.44 |
| 2026-03-16 | 35.72 |
| 2026-03-13 | 35.39 |
| 2026-03-12 | 35.09 |
| 2026-03-11 | 35.64 |
| 2026-03-10 | 35.81 |
| 2026-03-09 | 36.80 |
| 2026-03-06 | 36.52 |
| 2026-03-05 | 37.36 |
| 2026-03-04 | 36.96 |
| 2026-03-03 | 37.80 |
| 2026-03-02 | 39.01 |
| 2026-02-27 | 39.34 |
| 2026-02-26 | 38.77 |
| 2026-02-25 | 37.61 |
| 2026-02-24 | 38.47 |
| 2026-02-23 | 38.07 |
| 2026-02-20 | 38.17 |
| 2026-02-19 | 38.76 |
| 2026-02-18 | 39.04 |
| 2026-02-17 | 39.05 |
| 2026-02-13 | 38.25 |
| 2026-02-12 | 37.94 |
| 2026-02-11 | 37.61 |
| 2026-02-10 | 38.01 |
| 2026-02-09 | 37.94 |
| 2026-02-06 | 39.04 |
| 2026-02-05 | 39.74 |
| 2026-02-04 | 38.65 |
| 2026-02-03 | 46.90 |
| 2026-02-02 | 47.02 |
| 2026-01-30 | 47.87 |
| 2026-01-29 | 47.26 |
| 2026-01-28 | 48.01 |
| 2026-01-27 | 47.92 |
| 2026-01-26 | 47.88 |
| 2026-01-23 | 47.35 |
| 2026-01-22 | 46.73 |